Scientist, Radiopharma Analytical Development

Aktis Oncology Inc•Boston, MA

5h•Onsite

About The Position

Aktis Oncology is a biotechnology company pioneering the discovery and development of a new class of targeted alpha radiopharmaceuticals to treat a broad range of solid tumor cancers. Founded and incubated by MPM Capital, the company has developed proprietary platforms to generate tumor targeting agents with ideal properties for alpha radiotherapy. Designed for high tumor penetration and long residence time, Aktis Oncology's molecules will quickly clear other areas of the body, thereby maximizing tumor elimination while minimizing side effects of treatment. This approach would enable clinicians to visualize and verify target engagement prior to exposure to therapeutic radioisotopes. Aktis Oncology is seeking a highly motivated Scientist to support analytical method development for AKTIS Oncology’s proprietary radiopharmaceutical drug products. The candidate will lead method development, optimization, validation, and troubleshooting of HPLC methods focused on purity and impurity profiling, including RP-HPLC and SEC-HPLC techniques. This role is critical in ensuring product quality, regulatory compliance, and successful advancement of radiopharmaceutical programs from early development through clinical manufacturing. The position will collaborate closely with cross-functional team members to ensure timely delivery of robust QC protocols. The ideal candidate has hands-on experience in radio-analytical chemistry, chromatographic method development, and GMP , handle CRO/CDMO, analytical environments. This role will report to the Director of Analytical Development and requires full-time on-site presence.

Requirements

PhD in Analytical Chemistry with 2+ years relevant industry, Radiochemistry, Pharmaceutical Sciences, or related field OR MS with 4+ years relevant industry experience OR BS with 6+ years relevant industry experience
Hands-on experience with RP-HPLC and SEC-HPLC method development in purity and impurity, method validation and transfer in support of drug product is essential.
Stability study design and forced degradation expertise.
Experience analyzing radiolabeled compounds, Experience with gamma detectors, UV, radio detector and mass-based detection
Strong understanding of chemical purity and impurity analysis
Familiarity with GMP analytical laboratories
Experience with radioactive detectors and radio-HPLC systems (Agilent 1260 with Open lab CDS software)
Knowledge of ICH method validation guidelines
Project management and organizational skills, proven track record of setting priorities, and ability to work independently and as a team member.
Strong desire to be part of a mission‐oriented company leading transformative change for patients.
Proven demonstration of transparent communication and fostering open and diverse debate.
Ability to work with agility and manage ambiguity.
Personifies positive energy and exemplifies respect.

Responsibilities

Develop and optimize RP-, IEX- and SEC-HPLC methods for chemical and radiochemical purity and impurity analysis
Design stability-indicating analytical methods for radiopharmaceutical drug substances and drug products
Perform method validation in compliance with ICH and GMP guidelines
Troubleshoot complex chromatographic issues related to radiolabeled compounds, radiochemical impurities.
Conduct radiochemical impurity profiling and forced degradation studies
Support batch release testing and QC investigations
Write and review analytical protocols, reports, SOPs, and validation documentation
Collaborate with CMC, pre-clinical and process development, and manufacturing teams
Maintain compliance with radiation safety and GMP laboratory standards
Operate and maintain radio-HPLC systems, detectors, and analytical instruments
Participate in regulatory submissions by preparing analytical sections
Train junior staff and contribute to continuous process improvement